Larvol Delta - 858-Therapeutics-Announces-Initial-Data-from-FirstinHuman-Phase-12-Trial-of-PARG-Inhibitor-ETX19477-to-be-Presented-at-2026-ASCO-Annual-Meeting

ETX-19477 - 858 Therap

https://www.businesswire.com/news/home/20260521188410/en/858-Therapeutics-Announces-Initial-Data-from-First-in-Human-Phase-12-Trial-of-PARG-Inhibitor-ETX-19477-to-be-Presented-at-2026-ASCO-Annual-Meeting

May 21, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next